Welcome to Iris Biotech
For better service please confirm your country and language we detected.
Währung
EUR
Schneller Kontakt
Bitte senden Sie mir mehr Informationen über
Fmoc-L-Lys(Ggu-L-Glu(AA-AA))-OH
Chemischer Name: Fmoc-Lys(tBu-OOC-C16-CO-Glu(AEEA-AEEA)-OtBu)-OH // Synonyme: (23S,50S)-50-(((9H-fluoren-9-yl)methoxy)carbonylamino)-23-(tert-butoxycarbonyl)-2,2-dimethyl-4,21,26,35,44-pentaoxo-3,30,33,39,42-pentaoxa-22,27,36,45-tetraazahenpentacontan-51-oicacid, Semaglutide- Linker, Fmoc-Lys(Ggu-L-Glu(AA-AA)-OH
- Art-Nr.:FAA7640
- CAS Nr.:1662688-20-1
- Lagertemperatur:-20°C
- Formel:C64H101N5O16
- Molare Masse:1196,51 g/mol
Ab 390,00 €
description
Dipeptide building block for SPPS synthesis of Semaglutide (brand name Ozempic). Semaglutide is a GLP-1 analogue and has been developed in 2012 by Novo Nordisk SA for the treatment of diabetes type 2 as a longer-acting alternative to liraglutide. It was found in 2017 that it also can be used for the treatment of obesity.
references
"Abstracts of the 48th EASD Annual Meeting of the European Association for the Study of Diabetes". Diabetologia 2012; 55(1): 1–538. DOI: 10.1007/s00125-012-2688-9.
Benötigen Sie weitere Informationen über dieses Produkt?
kontaktieren Sie uns
Broschüren & Flyer
Produkte, die Sie auch interessieren könnten!
